insurance changes for glp-1 drugs Upcoming Medications: What You Need to Know Insurance coverage just changed for
Description
The phase IIIb clinical trial directly comparing both medications (SURMOUNT-5) is ongoing [38]
Stevens R
The FDA considers you clinically obese, and GLP-1 medications are approved for your use regardless of whether you have any other health complications
Additionally, Ozempic, Wegovy, Mounjaro and Zepbound will be available at $245 for patients on Medicare with a copay of $50 per month as soon as April 1, 2026
Long-term studies suggest continued use of both tirzepatide and semaglutide is necessary to maintain weight loss
As mentioned, the GLP-1 drugs work best alongside lifestyle and diet changes, as well as exercise, so start there
